Summary
CVS Health Corporation reported a net loss of $3.98 billion for the third quarter of 2025, a significant downturn from the prior year's net income of $87 million. This substantial decline was primarily driven by a goodwill impairment charge of $5.7 billion related to its Health Care Delivery reporting unit, compounded by ongoing litigation expenses, including opioid-related charges. Despite the reported net loss, total revenues saw a healthy increase of 7.8% to $102.9 billion for the quarter, driven by growth across all segments, particularly in 'Products' and 'Premiums'. The company's Health Services segment experienced robust revenue growth, though its adjusted operating income saw a slight decrease. The Pharmacy & Consumer Wellness segment also reported revenue growth, with strong same-store sales, but faced pressure on adjusted operating income due to reimbursement challenges and increased investments. The Health Care Benefits segment showed significant improvement in its adjusted operating income, benefiting from favorable premium deficiency reserve adjustments and strong performance in its government business.
Financial Highlights
54 data points| Revenue | $102.87B |
| Cost of Revenue | $57.05B |
| Gross Profit | $45.83B |
| Operating Expenses | $106.08B |
| Operating Income | -$3.21B |
| Net Income | -$3.98B |
| EPS (Basic) | $-3.13 |
| EPS (Diluted) | $-3.13 |
| Shares Outstanding (Basic) | 1.27B |
| Shares Outstanding (Diluted) | 1.27B |
Key Highlights
- 1Net loss of $3.98 billion for the third quarter of 2025, compared to a net income of $87 million in the prior year.
- 2Significant goodwill impairment charge of $5.7 billion recognized for the Health Care Delivery reporting unit.
- 3Total revenues increased by 7.8% to $102.9 billion for the quarter, indicating top-line growth across segments.
- 4Health Care Benefits segment's adjusted operating income improved substantially, turning from a loss to a profit, driven by favorable reserve adjustments and government business performance.
- 5Health Services segment revenue grew by 11.6%, but adjusted operating income decreased by 7.0% due to client price improvements and increased investment.
- 6Pharmacy & Consumer Wellness segment revenue increased by 11.7%, with strong same-store sales, but adjusted operating income declined by 7.4% due to reimbursement pressure and investments.
- 7Company continues to manage substantial litigation risks, with ongoing opioid litigation and other legal proceedings impacting financial results.